Polycomb repressive complex 2 is a critical mediator of allergic inflammation
Publication Year 2019-05-16, Volume 4, Issue #10, Page pii: 127745
Journal Title
JCI Insight
Publication Type
Journal Article
Strategies that intervene with the development of immune-mediated diseases are urgently needed, as current treatments mostly focus on alleviating symptoms rather than reversing the disease. Targeting enzymes involved in epigenetic modifications to chromatin represents an alternative strategy that has the potential to perturb the function of the lymphocytes that drive the immune response. Here, we report that 2 major epigenetic silencing pathways are increased after T cell activation. By specific inactivation of these molecules in the T cell compartment in vivo, we demonstrate that the polycomb repressive complex 2 (PRC2) is essential for the generation of allergic responses. Furthermore, we show that small-molecule inhibition of the PRC2 methyltransferase, enhancer of zeste homolog 2 (Ezh2), reduces allergic inflammation in mice. Therefore, by systematically surveying the pathways involved in epigenetic gene silencing we have identified Ezh2 as a target for the suppression of allergic disease.
American Society for Clinical Investigation
WEHI Research Division(s)
Immunology; Bioinformatics
PubMed ID
NHMRC Grants
NHMRC/1058238 NHMRC/1054925
Rights Notice
Refer to copyright notice on published article.

Creation Date: 2019-06-14 09:36:59
Last Modified: 2019-06-14 11:18:23
An error has occurred. This application may no longer respond until reloaded. Reload 🗙